TY - JOUR AU - Xu, Y. AU - Wang, L. AU - He, J. AU - Bi, Y. AU - Li, M. AU - Wang, T. PY - 2013 DA - 2013// TI - Prevalence and control of diabetes in Chinese adults JO - JAMA VL - 310 UR - https://doi.org/10.1001/jama.2013.168118 DO - 10.1001/jama.2013.168118 ID - Xu2013 ER - TY - JOUR PY - 2013 DA - 2013// TI - Standards of medical care in diabetes—2013 JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc13-S011 DO - 10.2337/dc13-S011 ID - ref2 ER - TY - JOUR AU - Eckel, R. H. AU - Wassef, M. AU - Chait, A. AU - Sobel, B. AU - Barrett, E. AU - King, G. PY - 2002 DA - 2002// TI - Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes JO - Circulation VL - 105 UR - https://doi.org/10.1161/01.CIR.0000013954.65303.C5 DO - 10.1161/01.CIR.0000013954.65303.C5 ID - Eckel2002 ER - TY - JOUR AU - Freeman, D. J. AU - Norrie, J. AU - Caslake, M. J. AU - Gaw, A. AU - Ford, I. AU - Lowe, G. D. PY - 2002 DA - 2002// TI - C reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevntion Study JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.5.1596 DO - 10.2337/diabetes.51.5.1596 ID - Freeman2002 ER - TY - JOUR AU - Festa, A. AU - D’Agostino, R. AU - Tracy, R. P. AU - Haffner, S. M. PY - 2002 DA - 2002// TI - Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes mellitus: the Insulin Resistance Atherosclerosis Study (IRSA) JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.4.1131 DO - 10.2337/diabetes.51.4.1131 ID - Festa2002 ER - TY - JOUR AU - Yekollu, S. K. AU - Thomas, R. AU - O’Sulivan, B. PY - 2011 DA - 2011// TI - Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice JO - Diabetes VL - 60 UR - https://doi.org/10.2337/db11-0275 DO - 10.2337/db11-0275 ID - Yekollu2011 ER - TY - JOUR AU - Mallat, Z. AU - Lambeau, G. AU - Tedgui, A. PY - 2010 DA - 2010// TI - Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: roles as biological effectors and biomarkers JO - Circulation VL - 122 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.936393 DO - 10.1161/CIRCULATIONAHA.110.936393 ID - Mallat2010 ER - TY - JOUR AU - Sarlon-Bartoli, G. AU - Boudes, A. AU - Buffat, C. AU - Bartoli, M. A. AU - Piercecchi-Marti, M. D. AU - Sarlon, E. PY - 2012 DA - 2012// TI - Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque JO - Eur J Vasc Endovasc Surg VL - 43 UR - https://doi.org/10.1016/j.ejvs.2011.10.009 DO - 10.1016/j.ejvs.2011.10.009 ID - Sarlon-Bartoli2012 ER - TY - JOUR AU - Masuda, S. AU - Murakami, M. AU - Komiyama, K. AU - Ishihara, M. AU - Ishikawa, Y. AU - Ishii, T. AU - Kudo, I. PY - 2005 DA - 2005// TI - Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells JO - FEBS J VL - 272 UR - https://doi.org/10.1111/j.1742-4658.2004.04489.x DO - 10.1111/j.1742-4658.2004.04489.x ID - Masuda2005 ER - TY - JOUR AU - Oshimoto, H. AU - Okamura, S. AU - Iida, T. AU - Ishikawa, T. AU - Hosaka, K. AU - Mori, M. PY - 2005 DA - 2005// TI - Diagnostic value of the serum platelet-activating factor acetylhydrolase activity in inflammatory bowel disease JO - Tohoku J Exp Med VL - 207 UR - https://doi.org/10.1620/tjem.207.65 DO - 10.1620/tjem.207.65 ID - Oshimoto2005 ER - TY - JOUR AU - Nelson, T. L. AU - Biggs, M. L. AU - Kizer, J. R. AU - Cushman, M. AU - Hokanson, J. E. AU - Furberg, C. D. AU - Mukamal, K. J. PY - 2012 DA - 2012// TI - Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study JO - J Clin Endocrin Metab VL - 97 UR - https://doi.org/10.1210/jc.2011-3026 DO - 10.1210/jc.2011-3026 ID - Nelson2012 ER - TY - JOUR AU - Thompson, A. AU - Gao, P. AU - Orfei, L. AU - Watson, S. AU - Angelantonio, E. AU - Kaptoge, S. PY - 2010 DA - 2010// TI - Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(10)60319-4 DO - 10.1016/S0140-6736(10)60319-4 ID - Thompson2010 ER - TY - JOUR AU - Weng, J. AU - Li, Y. AU - Xu, W. AU - Shi, L. AU - Zhang, Q. AU - Zhu, D. PY - 2008 DA - 2008// TI - Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60762-X DO - 10.1016/S0140-6736(08)60762-X ID - Weng2008 ER - TY - JOUR AU - Holman, R. R. AU - Paul, S. K. AU - Bethel, M. A. AU - Matthews, D. R. AU - Neil, H. A. PY - 2008 DA - 2008// TI - 10-year follow-up of intensive glucose control in type 2 diabetes JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0806470 DO - 10.1056/NEJMoa0806470 ID - Holman2008 ER - TY - JOUR AU - Wang, Z. H. AU - Zhang, S. H. AU - Gong, L. L. AU - Ren, W. AU - Li, R. AU - Zheng, R. Z. PY - 2009 DA - 2009// TI - The impact of family history of type 2 diabetes on pancreatic β cell function JO - Diabetes Res Clin Pract VL - 86 UR - https://doi.org/10.1016/j.diabres.2009.04.004 DO - 10.1016/j.diabres.2009.04.004 ID - Wang2009 ER - TY - JOUR AU - Cai, A. AU - Li, G. AU - Chen, J. AU - Li, X. AU - Li, L. AU - Zhou, Y. PY - 2015 DA - 2015// TI - Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population JO - BMC Cardiovasc Disord VL - 15 UR - https://doi.org/10.1186/s12872-015-0001-9 DO - 10.1186/s12872-015-0001-9 ID - Cai2015 ER - TY - JOUR AU - Constantinides, A. AU - Pelt, L. J. AU - Leeuwen, J. J. AU - Vries, R. AU - Tio, R. A. AU - Horst, I. C. PY - 2011 DA - 2011// TI - Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes JO - Eur J Clin Invest VL - 41 UR - https://doi.org/10.1111/j.1365-2362.2011.02471.x DO - 10.1111/j.1365-2362.2011.02471.x ID - Constantinides2011 ER - TY - JOUR AU - Fortunato, J. AU - Blaha, V. AU - Bis, J. AU - St’asek, J. AU - Andrys, C. AU - Vojacek, J. PY - 2014 DA - 2014// TI - Lipoprotein-associated phospholipase A2 mass level is increased in elderly subjects with type 2 diabetes mellitus JO - J Diabetes Res VL - 2014 UR - https://doi.org/10.1155/2014/278063 DO - 10.1155/2014/278063 ID - Fortunato2014 ER - TY - JOUR AU - Rosenson, R. S. AU - Stafforini, D. M. PY - 2012 DA - 2012// TI - Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2 JO - J Lipid Res VL - 53 UR - https://doi.org/10.1194/jlr.R024190 DO - 10.1194/jlr.R024190 ID - Rosenson2012 ER - TY - JOUR AU - Sanchez-Quesada, J. L. AU - Vinagre, I. AU - Juan-Franco, E. AU - Sanchez-Hernandez, J. AU - Bonet-Marques, R. AU - Blanco-Vaca, F. PY - 2013 DA - 2013// TI - Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes JO - Cardiovasc Diabetol VL - 12 UR - https://doi.org/10.1186/1475-2840-12-112 DO - 10.1186/1475-2840-12-112 ID - Sanchez-Quesada2013 ER - TY - JOUR AU - Wilensky, R. L. AU - Shi, Y. AU - Mohler, E. R. AU - Hamamdzic, D. AU - Burgert, M. E. AU - Li, J. PY - 2008 DA - 2008// TI - Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm.1870 DO - 10.1038/nm.1870 ID - Wilensky2008 ER - TY - JOUR AU - Wang, W. Y. AU - Zhang, J. AU - Wu, W. Y. AU - Li, J. AU - Ma, Y. L. AU - Chen, W. H. PY - 2011 DA - 2011// TI - Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0023425 DO - 10.1371/journal.pone.0023425 ID - Wang2011 ER - TY - JOUR AU - O’Donoghue, M. L. AU - Braunwald, E. AU - White, H. D. AU - Lukas, M. A. AU - Tarka, E. AU - Steg, P. G. PY - 2014 DA - 2014// TI - Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial JO - JAMA VL - 312 UR - https://doi.org/10.1001/jama.2014.11061 DO - 10.1001/jama.2014.11061 ID - O’Donoghue2014 ER - TY - JOUR AU - Rosenson, R. S. AU - Fraser, H. AU - Goulder, M. A. AU - Hislop, C. PY - 2011 DA - 2011// TI - Anti-Inflammatory effects of varespladib methyl in diabetic patients with acute coronary syndrome JO - Cardiovasc Drugs Ther VL - 25 UR - https://doi.org/10.1007/s10557-011-6344-2 DO - 10.1007/s10557-011-6344-2 ID - Rosenson2011 ER - TY - JOUR AU - Vlachojannis, G. J. AU - Scholz-Pedretti, K. AU - Fierlbeck, W. PY - 2005 DA - 2005// TI - Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats JO - Clin Bephrol VL - 63 UR - https://doi.org/10.5414/CNP63356 DO - 10.5414/CNP63356 ID - Vlachojannis2005 ER - TY - JOUR AU - Okada, T. AU - Miyashita, M. AU - Kuromori, Y. AU - Iwata, F. AU - Harada, K. AU - Hattori, H. PY - 2006 DA - 2006// TI - Platelet-activating factor acetylhydrolase concentration in children with abdominal obesity JO - Arterioscler Thromb Vasc Biol VL - 26 UR - https://doi.org/10.1161/01.ATV.0000217284.86123.2c DO - 10.1161/01.ATV.0000217284.86123.2c ID - Okada2006 ER - TY - JOUR AU - Misso, N. L. AU - Petrovic, N. AU - Grove, C. AU - Celenza, A. AU - Brooks-Wildhaber, J. AU - Thompson, P. J. PY - 2008 DA - 2008// TI - Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration JO - Thorax VL - 63 UR - https://doi.org/10.1136/thx.2006.074112 DO - 10.1136/thx.2006.074112 ID - Misso2008 ER - TY - JOUR AU - Wan, D. H. AU - Fan, P. AU - Bai, H. AU - Song, Q. AU - Liu, H. W. PY - 2010 DA - 2010// TI - Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance JO - Zhonghua Fu Chan Ke Za Zhi VL - 45 ID - Wan2010 ER - TY - JOUR AU - Kudolo, G. B. AU - Bressler, P. AU - DeFrozo, R. A. PY - 1997 DA - 1997// TI - Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment JO - J Lipid Mediat Cell Signal VL - 17 UR - https://doi.org/10.1016/S0929-7855(97)00023-0 DO - 10.1016/S0929-7855(97)00023-0 ID - Kudolo1997 ER - TY - JOUR AU - Konukoglu, D. AU - Uzun, H. AU - Firtina, S. AU - Cigdem Arica, P. AU - Kocael, A. AU - Taskin, M. PY - 2007 DA - 2007// TI - Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients JO - Obes Surg VL - 17 UR - https://doi.org/10.1007/s11695-007-9113-3 DO - 10.1007/s11695-007-9113-3 ID - Konukoglu2007 ER - TY - JOUR AU - Friedman, J. E. AU - Kirwan, J. P. AU - Jing, M. AU - Presley, L. AU - Catalano, P. M. PY - 2008 DA - 2008// TI - Increased skeletal muscle tumor necrosis factor-α and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum JO - Diabetes VL - 57 UR - https://doi.org/10.2337/db07-1356 DO - 10.2337/db07-1356 ID - Friedman2008 ER - TY - JOUR AU - Cai, D. S. AU - Yuan, M. S. AU - Frantz, D. F. AU - Melendez, P. A. AU - Hansen, L. AU - Lee, J. AU - Shoelson, S. E. PY - 2005 DA - 2005// TI - Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB JO - Nat Med VL - 11 UR - https://doi.org/10.1038/nm1166 DO - 10.1038/nm1166 ID - Cai2005 ER - TY - JOUR AU - Noto, H. AU - Chitkara, P. AU - Raskin, P. PY - 2006 DA - 2006// TI - The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes JO - J Diabetes Complications VL - 20 UR - https://doi.org/10.1016/j.jdiacomp.2006.07.004 DO - 10.1016/j.jdiacomp.2006.07.004 ID - Noto2006 ER - TY - JOUR AU - Iwase, M. AU - Sonoki, K. AU - Sasaki, N. AU - Ohdo, S. AU - Higuchi, S. AU - Hattori, H. AU - Iida, M. PY - 2008 DA - 2008// TI - Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment JO - Atherosclerosis VL - 196 UR - https://doi.org/10.1016/j.atherosclerosis.2007.02.012 DO - 10.1016/j.atherosclerosis.2007.02.012 ID - Iwase2008 ER - TY - JOUR AU - Huang, Y. AU - Fu, J. F. AU - Shi, H. B. AU - Liu, L. R. PY - 2011 DA - 2011// TI - Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes JO - Zhonghua Er Ke Za Zhi VL - 49 ID - Huang2011 ER - TY - JOUR AU - Ramanadham, S. AU - Ma, Z. AU - Arita, H. AU - Zhang, S. AU - Turk, J. PY - 1998 DA - 1998// TI - Type IB secretory phospholipase A2 is contained in insulin secretory granules of pancreatic islet beta-cells and is co-secreted with insulin from glucose-stimulated islets JO - Biochim Biophys Acta VL - 1390 UR - https://doi.org/10.1016/S0005-2760(97)00189-6 DO - 10.1016/S0005-2760(97)00189-6 ID - Ramanadham1998 ER - TY - JOUR AU - Mayer, O. AU - Seidlerova, J. AU - Filipovsky, J. AU - Timoracka, K. AU - Bruthans, J. AU - Vanek, J. PY - 2014 DA - 2014// TI - Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease JO - Eur J Intern Med VL - 25 UR - https://doi.org/10.1016/j.ejim.2014.05.010 DO - 10.1016/j.ejim.2014.05.010 ID - Mayer2014 ER -